FUJIFILM Diosynth Biotechnologies is planning to construct a $2 billion biopharmaceutical production facility in Holly Springs, N.C.

Vibalogics is creating a 110,000-sf facility for the production of oncolytic viruses, viral vector vaccines, and viral vector gene therapy products in Boxborough, Mass.

Civica Rx began construction in early 2021 on a $124.5 million pharmaceutical manufacturing center in Petersburg, Va.

The Massachusetts Center for Advanced Biological Innovation and Manufacturing is planning to create a 40,000-sf facility in Watertown, Mass.

Thermo Fisher Scientific is expanding its global production capacity for vaccines, medicines, and biologic therapies.

Nationwide Children's Hospital is constructing a $100 million gene therapy manufacturing center in Columbus, Ohio.

Ultragenyx is planning to build a 100,000-sf gene therapy manufacturing facility in Bedford, Mass.

CPI began construction in October of 2020 on the Medicines Manufacturing Innovation Centre in Inchinnan in the United Kingdom.

Merck is constructing a $69 million facility for the production of high-potency active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) compounds.

Facility Logix, EwingCole, and Biggins Lacy Shapiro have launched Rapid Reshore & Development (RR&D) to provide turnkey p